Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

Loricera J, J; Castañeda, S; Moriano, C; Narváez, J; Aldasoro, V; Maiz, O; Melero, R; Villa, I; Vela, P; Romero-Yuste, S; Callejas Rubio, José Luis

doi:10.1177/1759720X221113747

toci viausl acg therapeutic advances musculoskeletal disease 2023.pdf (998.8Kb)

Identificadores

URI: https://hdl.handle.net/10481/100732

DOI: 10.1177/1759720X221113747

Exportar

Editorial

Ther Adv Musculoskelet Dis

Date

2022-07

Referencia bibliográfica

Loricera J, Castañeda S, Moriano C, Narváez J, Aldasoro V, Maiz O, Melero R, Villa I, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sánchez-Martín J, Sánchez-Bilbao L, Calderón-Goercke M, Casado A, Hernández JL, González-Gay MA, Blanco R. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients. Ther Adv Musculoskelet Dis. 2022 Jul 22;14:1759720X221113747. doi: 10.1177/1759720X221113747. (IF: 5.35; Q1)

Collections

DMed - Artículos

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional